The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2229-2240

  Sa, Susan M ^a   Valdez, Patricia A ^a   Wu, Jianfeng ^a   Jung, Kenneth ^a   Zhong, Fiona ^a   Hall, Linda ^a   Kasman, Ian ^a   Winer, Jane ^a   Modrusan, Zora ^a   Danilenko, Dimitry M ^a   Ouyang, Wenjun ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CHEMOKINE; CYTOKERATIN 16; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; KALLIKREIN; PROTEIN S 100; PSORIASIN; STAT3 PROTEIN;

ACANTHOSIS; ADAPTIVE IMMUNITY; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; EPITHELIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRANULAR CELL; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS;

EID: 33846940253     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2229     Document Type: Article

References (74)

1. Nickoloff, B. J., and F. O. Nestle. 2004. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 113: 1664-1675.
2. Bowcock, A. M., and J. G. Krueger. 2005. Getting under the skin: the immunogenetics of psoriasis. Nat. Rev. Immunol. 5: 699-711.
3. Uyemura, K., M. Yamamura, D. F. Fivenson, R. L. Modlin, and B. J. Nickoloff. 1993. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101: 701-705.
4. Schlaak, J. F., M. Buslau, W. Jochum, E. Hermann, M. Girndt, H. Gallati, K. H. Meyer zum Buschenfelde, and B. Fleischer. 1994. T cells involved in Psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102: 145-149.
5. Kauffman, C. L., N. Aria, E. Toichi, T. S. McCormick, K. D. Cooper, A. B. Gottlieb, D. E. Everitt, B. Frederick, Y. Zhu, M. A. Graham, et al. 2004. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J. Invest. Dermatol. 123: 1037-1044.
6. Lee, E., W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, and J. G. Krueger. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with Psoriasis vulgaris. J. Exp. Med. 199: 125-130.
7. Kupper, T. S., and R. C. Fuhlbrigge. 2004. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4: 211-222.
8. Sano, S., K. S. Chan, S. Carbajal, J. Clifford, M. Peavey, K. Kiguchi, S. Itami, B. J. Nickoloff, and J. DiGiovanni. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11: 43-49.
9. Piepkorn, M., M. R. Pittelkow, and P. W. Cook. 1998. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J. Invest. Dermatol. 111: 715-721.
10. Otkjaer, K., K. Kragballe, A. T. Funding, J. T. Clausen, P. L. Noerby, T. Steiniche, and L. Iversen. 2005. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br. J. Dermatol. 153: 911-918.
11. Blumberg, H., D. Conklin, W. F. Xu, A. Grossmann, T. Brender, S. Carollo, M. Eagan, D. Foster, B. A. Haldeman, A. Hammond, et al. 2001. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104: 9-19.
12. Romer, J., E. Hasselager, P. L. Norby, T. Steiniche, J. Thorn Clausen, and K. Kragballe. 2003. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol. J. Invest. Dermatol. 121: 1306-1311.
13. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
14. Boniface, K., F. X. Bernard, M. Garcia, A. L. Gurney, J. C. Lecron, and F. Morel. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174: 3695-3702.
15. Wolk, K., E. Witte, E. Wallace, W.-D. Docke, S. Kunz, K. Asadullah, H.-D. Volk, W. Sterry, and R. Sabat. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36: 1309-1323.
16. Kotenko, S. V., and J. A. Langer. 2004. Full house: 12 receptors for 27 cytokines. Int. Immunopharmacol. 4: 593-608.
17. Wolk, K., S. Kunz, K. Asadullah, and R. Sabat. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168: 5397-5402.
18. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979.
19. Renauld, J.-C. 2003. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 3: 667-676.
20. Jiang, H., J. J. Lin, Z. Z. Su, N. I. Goldstein, and P. B. Fisher. 1995. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486.
21. Soo, C., W. W. Shaw, E. Freymiller, M. T. Longaker, C. N. Bertolami, R. Chiu, A. Tieu, and K. Ting. 1999. Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. J. Cell Biochem. 74: 1-10.
22. Ekmekcioglu, S., J. Ellerhorst, A. M. Mhashilkar, A. A. Sahin, C. M. Read, V. G. Prieto, S. Chada, and E. A. Grimm. 2001. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int. J. Cancer 94: 54-59.
23. Dumoutier, L., C. Leemans, D. Lejeune, S. V. Kotenko, and J. C. Renauld. 2001. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167: 3545-3549.
24. Wang, M., Z. Tan, R. Zhang, S. V. Kotenko, and P. Liang. 2002. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem. 277: 7341-7347.
25. Parrish-Novak, J., W. Xu, T. Brender, L. Yao, C. Jones, J. West, C. Brandt, L. Jelinek, K. Madden, P. A. McKernan, et al. 2002. Interleukins 19, 20, and 24 signal through two distinct receptor complexes: differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem. 277: 47517-47523.
26. Xie, M. H., S. Aggarwal, W. H. Ho, J. Foster, Z. Zhang, J. Stinson, W. I. Wood, A. D. Goddard, and A. L. Gurney. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275: 31335-31339.
27. Kotenko, S. V., L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 276: 2725-2732.
28. Sheikh, F., V. V. Baurin, A. Lewis-Antes, N. K. Shah, S. V. Smirnov, S. Anantha, H. Dickensheets, L. Dumoutier, J. C. Renauld, A. Zdanov, et al. 2004. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J. Immunol. 172: 2006-2010.
29. Hor, S., H. Pirzer, L. Dumoutier, F. Bauer, S. Wittmann, H. Sticht, J.-C. Renauld, R. de Waal Malefyt, and H. Fickenscher. 2004. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J. Biol. Chem. 279: 33343-33351.
30. Aggarwal, S., M. H. Xie, M. Maruoka, J. Foster, and A. L. Gurney. 2001. Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 21: 1047-1053.
31. Li, H. H., Y. C. Lin, P. J. Chen, C. H. Hsiao, J. Y. Lee, W. C. Chen, T. Y. Tzung, J. C. Wu, and M. S. Chang. 2005. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br. J. Dermatol. 153: 591-595.
32. Wei, C. C., W. Y. Chen, Y. C. Wang, P. J. Chen, J. Y. Lee, T. W. Wong, W. C. Chen, J. C. Wu, G. Y. Chen, M. S. Chang, and Y. C. Lin. 2005. Detection of IL-20 and its receptors on psoriatic skin. Clin. Immunol. 117: 65-72.
33. Liu, L., C. Ding, W. Zeng, J. G. Heuer, J. W. Tetreault, T. W. Noblitt, G. Hangoc, S. Cooper, K. A. Brune, G. Sharma, et al. 2003. Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. Blood 102: 3206-3209.
34. Jordan, W. J., J. Eskdale, M. Boniotto, G. P. Lennon, J. Peat, J. D. M. Campbell, and G. Gallagher. 2005. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur. J. Immunol. 35: 1576-1582.
35. Choe, S. E., M. Boutros, A. M. Michelson, G. M. Church, and M. S. Halfon. 2005. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol. 6: R16.
36. Storey, J. D., and R. Tibshirani. 2003. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100: 9440-9445.
37. Long, A. D., H. J. Mangalam, B. Y. Chan, L. Tolleri, G. W. Hatfield, and P. Baldi. 2001. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J. Biol. Chem. 276: 19937-19944.
38. Zhou, X., J. G. Krueger, M.-C. J. Kao, E. Lee, F. Du, A. Menter, W. H. Wong, and A. M. Bowcock. 2003. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol. Genomics 13: 69-78.
39. Murphy, G. F. 1995. Dermatopathology: A Practical Guide to Common Disorders. W. B. Saunders, Philadelphia, pp. 73-77.
40. Zhong, Z., Z. Wen, and J. E. Darnell, Jr. 1994. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98.
41. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277: 1630-1635.
42. Nickoloff, B. J. 1991. The cytokine network in psoriasis. Arch. Dermatol. 127: 871-884.
43. Lew, W., A. M. Bowcock, and J. G. Krueger. 2004. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol. 25: 295-305.
44. Singer, A. J., and R. A. Clark. 1999. Cutaneous wound healing. N. Engl. J. Med. 341: 738-746.
45. Ishida-Yamamoto, A., Y. Hashimoto, M. Manabe, W. M. O'Guin, B. A. Dale, and H. Iizuka. 1997. Distinctive expression of filaggrin and trichohyalin during various pathways of epithelial differentiation. Br. J. Dermatol. 137: 9-16.
46. Manabe, M., and W. M. O'Guin. 1994. Existence of trichohyalin- keratohyalin hybrid granules: co-localization of two major intermediate filament-associated proteins in non-follicular epithelia. Differentiation 58: 65-75.
47. Lee, S. C., M. Wang, O. W. McBride, E. J. O'Keefe, I. G. Kim, and P. M. Steinert. 1993. Human trichohyalin gene is clustered with the genes for other epidermal structural proteins and calcium-binding proteins at chromosomal locus 1q21. J. Invest. Dermatol. 100: 65-68.
48. Oestreicher, J. L., I. B. Walters, T. Kikuchi, P. Gilleaudeau, J. Surette, U. Schwertschlag, A. J. Dorner, J. G. Krueger, and W. L. Trepicchio. 2001. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J. 1: 272-287.
49. Bowcock, A. M., W. Shannon, F. Du, J. Duncan, K. Cao, K. Aftergut, J. Catier, M. A. Fernandez-Vina, and A. Menter. 2001. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 10: 1793-1805.
50. Westergaard, M., J. Henningsen, C. Johansen, S. Rasmussen, M. L. Svendsen, U. B. Jensen, H. D. Schroder, B. Staels, L. Iversen, L. Bolund, et al. 2003. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor κB in normal and lesional psoriatic skin. J. Invest. Dermatol. 121: 1104-1117.
51. Eckert, R. L., A.-M. Broome, M. Ruse, N. Robinson, D. Ryan, and K. Lee. 2004. S100 proteins in the epidermis. J. Invest. Dermatol. 123: 23-33.
52. Jinquan, T., H. Vorum, C. G. Larsen, P. Madsen, H. H. Rasmussen, B. Gesser, M. Etzerodt, B. Honore, J. E. Celis, and K. Thestrup-Pedersen. 1996. Psoriasin: a novel chemotactic protein. J. Invest. Dermatol. 107: 5-10.
53. Glaser, R., J. Harder, H. Lange, J. Bartels, E. Christophers, and J.-M. Schroder. 2005. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6: 57-64.
54. Nagalakshmi, M. L., E. Murphy, T. McClanahan, and R. de Waal Malefyt. 2004. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int. Immunopharmacol. 4: 577-592.
55. + myeloid-derived cells in psoriasis: gene regulation and cellular effects. J. Invest. Dermatol. 126: 1590-1599.
56. Banno, T., M. Adachi, L. Mukkamala, and M. Blumenberg. 2003. Unique keratinocyte-specific effects of interferon-γ that protect skin from viruses, identified using transcriptional profiling. Antiviral Ther. 8: 541-554.
57. Murphy, J. E., C. Robert, and T. S. Kupper. 2000. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J. Invest. Dermatol. 114: 602-608.
58. Banno, T., A. Gazel, and M. Blumenberg. 2004. Effects of tumor necrosis factor-α (TNF α) in epidermal keratinocytes revealed using global transcriptional profiling. J. Biol. Chem. 279: 32633-32642.
59. Cook, P. W., M. Piepkorn, C. H. Clegg, G. D. Plowman, J. M. DeMay, J. R. Brown, and M. R. Pittelkow. 1997. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. 100: 2286-2294.
60. Cook, P. W., M. R. Pittelkow, and M. Piepkorn. 1999. Overexpression of amphiregulin in the epidermis of transgenic mice induces a psoriasis-like cutaneous phenotype. J. Invest. Dermatol. 113: 860.
61. Piepkorn, M. 1996. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. Am. J. Dermatopathol. 18: 165-171.
62. Piepkorn, M., H. Predd, R. Underwood, and P. Cook. 2003. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch. Dermatol Res. 295: 93-101.
63. Cook, P. W., J. R. Brown, K. A. Cornell, and M. R. Pittelkow. 2004. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp. Dermatol. 13: 347-356.
64. Bhagavathula, N., K. C. Nerusu, G. J. Fisher, G. Liu, A. B. Thakur, L. Gemmell, S. Kumar, Z. H. Xu, P. Hinton, N. Tsurushita, et al. 2005. Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Am. J. Pathol. 166: 1009-1016.
65. Zdanov, A. 2004. Structural features of the interleukin-10 family of cytokines. Curr. Pharm. Des. 10: 3873-3884.
66. Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, et al. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984.
67. Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S. T. Eichhorst, J.-M. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, et al. 2006. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G827-G838.
68. Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52: 1037-1046.
69. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. In press.
70. Iwakura, Y., and H. Ishigame. 2006. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116: 1218-1222.
71. Komatsu, N., K. Saijoh, T. Toyama, R. Ohka, N. Otsuki, G. Hussack, K. Takehara, and E. P. Diamandis. 2005. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br. J. Dermatol. 153: 274-281.
72. Brattsand, M., K. Stefansson, C. Lundh, Y. Haasum, and T. Egelrud. 2005. A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124: 198-203.
73. Caubet, C., N. Jonca, M. Brattsand, M. Guerrin, D. Bernard, R. Schmidt, T. Egelrud, M. Simon, and G. Serre. 2004. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122: 1235-1244.
74. de Jongh, G. J., P. L. Zeeuwen, M. Kucharekova, R. Pfundt, P. G. van der Valk, W. Blokx, A. Dogan, P. S. Hiemstra, P. C. van de Kerkhof, and J. Schalkwijk. 2005. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J. Invest. Dermatol. 125: 1163-1173.